PoC in Rheumatoid Arthritis With Methotrexate

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions
Rheumatoid Arthritis, NOS
Interventions
DRUG

BMS-582949

Tablets, Oral, 300 mg, once daily, 12 weeks

DRUG

Placebo

Tablets, Oral, placebo, once daily, 12 weeks

Trial Locations (28)

333

Local Institution, Taoyuan District

1426

Local Institution, Buenos Aires

1431

Local Institution, Capital Federal

8000

Local Institution, Culiacán

14080

Local Institution, Mexico City

15706

Local Institution, Santiago de C.

19152

The Arthritis Group, Philadelphia

28046

Local Institution, Madrid

33076

Local Institution, Bordeaux

37170

Local Institution, Chambray-lès-Tours

38305

Arthritis Clinic, Jackson

44200

Local Institution, Guadalajara

44500

Local Institution, Guadalajara

48903

Local Institution, Vizcaya

64020

Local Institution, Nuevo León

73103

Health Research Of Oklahoma, Oklahoma City

75679

Local Institution, Paris

78705

Walter F Chase Md, Austin

81928

G. Timothy Kelly, Md, Las Vegas

90404

Orrin M. Troum,M D, Santa Monica

92260

Desert Medical Advances, Palm Desert

98405

Tacoma Center For Arthritis Research Ps, Tacoma

C1034ACO

Local Institution, Ciudad Autonoma de Buenos Aire

370 01

Local Institution, České Budějovice

500 05

Local Institution, Hradec Králové

128 50

Local Institution, Prague

330-721

Local Institution, Cheonan

B

Local Institution, Taichung

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY